Rapid antibody development yields possible treatment for yellow fever

The experimental drug has shown promise in early-stage clinical trials conducted in Singapore.

Anne Trafton | MIT News Office • mit
July 29, 2020 ~8 min

Finch Therapeutics unleashes the power of the gut

The company is developing treatments that restore gut bacteria in people struggling with a range of diseases.

Zach Winn | MIT News Office • mit
July 23, 2020 ~8 min


Engineers use “DNA origami” to identify vaccine design rules

In lab tests, virus-like DNA structures coated with viral proteins provoke a strong immune response in human B cells.

Anne Trafton | MIT News Office • mit
June 29, 2020 ~7 min

A focused approach to imaging neural activity in the brain

New molecule for imaging calcium in neurons reduces crosstalk from neighboring neurons.

Anne Trafton | MIT News Office • mit
June 26, 2020 ~7 min

Experimental peptide targets Covid-19

Computational modeling yields a protein fragment that could bind to coronavirus spike proteins and destroy them.

Anne Trafton | MIT News Office • mit
June 22, 2020 ~6 min

MIT-Takeda program launches

Research projects will harness the power of artificial intelligence to positively impact human health.

School of Engineering • mit
June 18, 2020 ~7 min

Counting your antigens

A new platform that precisely quantifies antigens presented on cell surfaces may help researchers and clinicians improve the effectiveness of cancer immunotherapies.

Bendta Schroeder | Koch Institute • mit
June 2, 2020 ~9 min

SMART researchers uncover new anti-phage defense mechanisms

Discovery explains why some bacteria have been able to defend against phage therapy, opens new ways to overcome existing challenges.

Singapore-MIT Alliance for Research and Technology • mit
May 13, 2020 ~5 min


3 Questions: Michael Yaffe on treating Covid-19 patients with acute respiratory distress

MIT professor and intensivist/trauma surgeon explains the new challenges that Covid-19 brings to treating patients in acute respiratory distress.

Bendta Schroeder | Koch Institute • mit
April 29, 2020 ~7 min

MIT’s Love Lab developing a Covid-19 vaccine to potentially reach billions

Manufacturability is key to producing a widely available, affordable vaccine.

Ashley Belanger | School of Engineering • mit
April 22, 2020 ~8 min

/

47